These are this Monday’s top analyst upgrades, downgrades and initiations from Wall Street analysts.
Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) was raised to Overweight from Neutral at Piper Jaffray with a $10 price target (versus $7.36 close and versus $7.90 early indications), and it was raised to Outperform from Market Perform at Wells Fargo.
Central European Media Enterprises Ltd. (NASDAQ: CETV) was raised to Neutral from Sell at Goldman Sachs.
Chuy’s Holdings, Inc. (NASDAQ: CHUY) was raised to Outperform from Market Perform at Raymond James.
Freeport-McMoRan Copper & Gold Inc. (NYSE: FCX) was raised to Buy from Hold with a $42 price target (versus a $36.49 close) at Argus.
Gilead Sciences Inc. (NASDAQ: GILD) was reiterated as Buy and the price target to $110 from $90 at Argus. The call reflects strong Sovaldi sales for Hep-C and continued growth from both new and established products.
The Gap, Inc. (NYSE: GPS) was started as Neutral at Credit Suisse.
GNC Holdings Inc. (NYSE: GNC) was raised to Outperform from Neutral with a $43 price target (versus $32.67 close) at Credit Suisse.
Gulfport Energy Corp. (NASDAQ: GPOR) was raised to Buy from Hold at Stifel.
Hyatt Hotels Corp. (NYSE: H) was raised to Buy from Hold at Stifel Nicolaus.
King Digital Entertainment PLC (NYSE: KING) was downgraded to Sector Perform from Outperform by Pacific Crest.
ALSO READ: 11 Analyst Stock Picks Under $10 With Massive Upside
PepsiCo Inc. (NYSE: PEP) was raised to Buy from Neutral at UBS.
2U, Inc. (NASDAQ: TWOU) had a massive run last week, rising from under $14 to just over $17. Now we have word that Goldman Sachs has downgraded the SaaS player for universities and non-profits to Neutral from Buy.
Tesla Motors, Inc. (NASDAQ: TSLA) was raised to Buy from Hold at Deutsche Bank, and the price target was moved all the way up to $310 from $222 (versus $248 close). This was on the heels of a new Outperform rating and $316 price target from Pacific Crest last week.
Thoratec Corp. (NASDAQ: THOR) was pounded on poor results last week, as well as several downgrades. Now, a day-after downgrade has been seen from Northland Securities, which downgraded the stock to Market Perform from Outperform and cut the price target down to $26 (versus $23.27 close).
Wal-Mart Stores Inc. (NYSE: WMT) was downgraded to Hold from Buy at Jefferies, but what stood out the most was the price target cut — down to $76 from $89 (versus $74.67 close).
ALSO READ: 4 Biotechs That Analysts See Rising 100% or More
In case you missed Friday’s top analyst upgrades and downgrades, they included shares of Zynga, Barrick, Allergan, BioCryst, Mylan, NVIDIA and a dozen or so more companies. Also on deck and of importance for this week:
Top Gaining Stocks
Top Losing Stocks